{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:12Z","timestamp":1793332452416,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09220-7","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T15:21:37Z","timestamp":1753456897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Podocyte dysfunction driven by heme in sickle-cell nephropathy"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8395-8806","authenticated-orcid":false,"given":"Chlo\u00e9","family":"Ben Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-5024","authenticated-orcid":false,"given":"Antoine","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Morvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Moktefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Anh","family":"Nguyen-Peyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Van Wynsberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Sakhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7007-1344","authenticated-orcid":false,"given":"Pablo","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-2550","authenticated-orcid":false,"given":"Vincent","family":"Audard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"H\u00e9nique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"9220_CR1","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato, G. J. et al. Sickle cell disease. Nat. Rev. Dis. Primers 4, 18010. https:\/\/doi.org\/10.1038\/nrdp.2018.10 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"9220_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.ajkd.2018.12.027","volume":"74","author":"VK Derebail","year":"2019","unstructured":"Derebail, V. K. et al. Progressive decline in estimated GFR in patients with sickle cell disease: an observational cohort study. Am. J. Kidney Dis. 74, 47\u201355. https:\/\/doi.org\/10.1053\/j.ajkd.2018.12.027 (2019).","journal-title":"Am. J. Kidney Dis."},{"key":"9220_CR3","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1681\/ASN.2002010084","volume":"17","author":"A Guasch","year":"2006","unstructured":"Guasch, A., Navarrete, J., Nass, K. & Zayas, C. F. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J. Am. Soc. Nephrol. 17, 2228\u20132235. https:\/\/doi.org\/10.1681\/ASN.2002010084 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9220_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/bjh.16113","volume":"187","author":"C G\u00e9rardin","year":"2019","unstructured":"G\u00e9rardin, C. et al. Survival and specific outcome of sickle cell disease patients after renal transplantation. Br. J. Haematol. 187, 676\u2013680. https:\/\/doi.org\/10.1111\/bjh.16113 (2019).","journal-title":"Br. J. Haematol."},{"key":"9220_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14040","author":"L Nielsen","year":"2016","unstructured":"Nielsen, L. et al. Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients. Br. J. Haematol. https:\/\/doi.org\/10.1111\/bjh.14040 (2016).","journal-title":"Br. J. Haematol."},{"key":"9220_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-022-00540-9","volume":"18","author":"KI Ataga","year":"2022","unstructured":"Ataga, K. I., Saraf, S. L. & Derebail, V. K. The nephropathy of sickle cell trait and sickle cell disease. Nat. Rev. Nephrol. 18, 361\u2013377. https:\/\/doi.org\/10.1038\/s41581-022-00540-9 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"9220_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1056\/NEJM199204023261402","volume":"326","author":"RJ Falk","year":"1992","unstructured":"Falk, R. J. et al. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl. J. Med. 326, 910\u2013915. https:\/\/doi.org\/10.1056\/NEJM199204023261402 (1992).","journal-title":"N Engl. J. Med."},{"key":"9220_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MD.0b013e3181ca59b6","volume":"89","author":"G Maigne","year":"2010","unstructured":"Maigne, G. et al. Glomerular lesions in patients with sickle cell disease. Med. (Baltimore) 89, 18\u201327. https:\/\/doi.org\/10.1097\/MD.0b013e3181ca59b6 (2010).","journal-title":"Med. (Baltimore)"},{"key":"9220_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3324\/haematol.2011.050336","volume":"97","author":"TG Day","year":"2012","unstructured":"Day, T. G. et al. Association between hemolysis and albuminuria in adults with sickle cell anemia. Haematologica 97, 201\u2013205. https:\/\/doi.org\/10.3324\/haematol.2011.050336 (2012).","journal-title":"Haematologica"},{"key":"9220_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjh.12690","volume":"164","author":"SL Saraf","year":"2014","unstructured":"Saraf, S. L. et al. Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br. J. Haematol. 164, 729\u2013739. https:\/\/doi.org\/10.1111\/bjh.12690 (2014).","journal-title":"Br. J. Haematol."},{"key":"9220_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.taap.2019.04.025","volume":"374","author":"H Kim","year":"2019","unstructured":"Kim, H., Yin, K., Falcon, D. M. & Xue, X. The interaction of Hemin and Sestrin2 modulates oxidative stress and colon tumor growth. Toxicol. Appl. Pharmacol. 374, 77\u201385. https:\/\/doi.org\/10.1016\/j.taap.2019.04.025 (2019).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"9220_CR12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","volume":"32","author":"U Muller-Eberhard","year":"1968","unstructured":"Muller-Eberhard, U. et al. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood 32, 811\u2013815. https:\/\/doi.org\/10.1182\/blood.V32.5.811.811 (1968).","journal-title":"Blood"},{"key":"9220_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1177\/15353702231157920","volume":"248","author":"M Vissa","year":"2023","unstructured":"Vissa, M. et al. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease. Exp. Biol. Med. (Maywood) 248, 897\u2013907. https:\/\/doi.org\/10.1177\/15353702231157920 (2023).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"9220_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/path.5011","volume":"244","author":"A Rubio-Navarro","year":"2018","unstructured":"Rubio-Navarro, A. et al. Podocytes are new cellular targets of haemoglobin-mediated renal damage. J. Pathol. 244, 296\u2013310. https:\/\/doi.org\/10.1002\/path.5011 (2018).","journal-title":"J. Pathol."},{"key":"9220_CR15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem, M. A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630\u2013638. https:\/\/doi.org\/10.1681\/ASN.V133630 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9220_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-60761-411-1_4","volume":"594","author":"E Eruslanov","year":"2010","unstructured":"Eruslanov, E. & Kusmartsev, S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol. 594, 57\u201372. https:\/\/doi.org\/10.1007\/978-1-60761-411-1_4 (2010).","journal-title":"Methods Mol. Biol."},{"key":"9220_CR17","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1089\/ars.2007.1787","volume":"9","author":"J Balla","year":"2007","unstructured":"Balla, J. et al. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox. Signal 9, 2119\u20132137. https:\/\/doi.org\/10.1089\/ars.2007.1787 (2007).","journal-title":"Antioxid Redox. Signal"},{"key":"9220_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/ars.2009.2822","volume":"12","author":"JD Belcher","year":"2010","unstructured":"Belcher, J. D. et al. Heme degradation and vascular injury. Antioxid Redox. Signal 12, 233\u2013248. https:\/\/doi.org\/10.1089\/ars.2009.2822 (2010).","journal-title":"Antioxid Redox. Signal"},{"key":"9220_CR19","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2174\/1570159X19666201230144109","volume":"19","author":"G Raghu","year":"2021","unstructured":"Raghu, G. et al. The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress. Curr. Neuropharmacol. 19, 1202\u20131224. https:\/\/doi.org\/10.2174\/1570159X19666201230144109 (2021).","journal-title":"Curr. Neuropharmacol."},{"key":"9220_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2018.08.005","volume":"133","author":"RK Donegan","year":"2019","unstructured":"Donegan, R. K., Moore, C. M., Hanna, D. A. & Reddi, A. R. Handling heme: the mechanisms underlying the movement of heme within and between cells. Free Radic. Biol. Med. 133, 88\u2013100. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.08.005 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"9220_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1182\/blood.v100.3.879","volume":"100","author":"V Jeney","year":"2002","unstructured":"Jeney, V. et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100, 879\u2013887. https:\/\/doi.org\/10.1182\/blood.v100.3.879 (2002).","journal-title":"Blood"},{"key":"9220_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1046\/j.1523-1755.2000.00261.x","volume":"58","author":"YK Lim","year":"2000","unstructured":"Lim, Y. K. et al. Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis. Kidney Int. 58, 1033\u20131044. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00261.x (2000).","journal-title":"Kidney Int."},{"key":"9220_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/10590500902885684","volume":"27","author":"A Valavanidis","year":"2009","unstructured":"Valavanidis, A., Vlachogianni, T. & Fiotakis, C. 8-hydroxy-2\u2019 -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 27, 120\u2013139. https:\/\/doi.org\/10.1080\/10590500902885684 (2009).","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"9220_CR24","first-page":"305","volume":"22","author":"LJ Kuo","year":"2008","unstructured":"Kuo, L. J. & Yang, L.-X. \u03b3-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 22, 305\u2013309 (2008).","journal-title":"In Vivo"},{"key":"9220_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1182\/blood.2020008455","volume":"139","author":"AV Menon","year":"2022","unstructured":"Menon, A. V. et al. Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease. Blood 139, 936\u2013941. https:\/\/doi.org\/10.1182\/blood.2020008455 (2022).","journal-title":"Blood"},{"key":"9220_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070680","author":"SJ Annesley","year":"2019","unstructured":"Annesley, S. J. & Fisher, P. R. Mitochondria in health and disease. Cells https:\/\/doi.org\/10.3390\/cells8070680 (2019).","journal-title":"Cells"},{"key":"9220_CR27","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1111\/bph.12503","volume":"171","author":"GC Higgins","year":"2014","unstructured":"Higgins, G. C. & Coughlan, M. T. Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?. Br. J. Pharmacol. 171, 1917\u20131942. https:\/\/doi.org\/10.1111\/bph.12503 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"9220_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/cells12010088","volume":"12","author":"H-J Ho","year":"2022","unstructured":"Ho, H.-J. & Shirakawa, H. Oxidative stress and mitochondrial dysfunction in chronic kidney disease. Cells 12, 88. https:\/\/doi.org\/10.3390\/cells12010088 (2022).","journal-title":"Cells"},{"key":"9220_CR29","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1681\/ASN.2013111202","volume":"26","author":"T Kawakami","year":"2015","unstructured":"Kawakami, T. et al. Deficient autophagy results in mitochondrial dysfunction and FSGS. JASN 26, 1040\u20131052. https:\/\/doi.org\/10.1681\/ASN.2013111202 (2015).","journal-title":"JASN"},{"key":"9220_CR30","doi-asserted-by":"publisher","first-page":"H1394","DOI":"10.1152\/ajpheart.00584.2011","volume":"302","author":"AN Higdon","year":"2012","unstructured":"Higdon, A. N. et al. Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy. Am. J. Physiol. Heart Circ. Physiol. 302, H1394-1409. https:\/\/doi.org\/10.1152\/ajpheart.00584.2011 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"9220_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2020.09.028","volume":"161","author":"L Cui","year":"2020","unstructured":"Cui, L. et al. Mitoquinone attenuates vascular calcification by suppressing oxidative stress and reducing apoptosis of vascular smooth muscle cells via the Keap1\/Nrf2 pathway. Free Radic. Biol. Med. 161, 23\u201331. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.09.028 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"9220_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fgene.2019.00435","volume":"10","author":"AP Gureev","year":"2019","unstructured":"Gureev, A. P., Shaforostova, E. A. & Popov, V. N. Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways. Front. Genet. 10, 435. https:\/\/doi.org\/10.3389\/fgene.2019.00435 (2019).","journal-title":"Front. Genet."},{"key":"9220_CR33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fphar.2019.00740","volume":"10","author":"A Rubio-Navarro","year":"2019","unstructured":"Rubio-Navarro, A. et al. Nrf2 plays a protective role against intravascular hemolysis-mediated acute kidney injury. Front. Pharmacol. 10, 740. https:\/\/doi.org\/10.3389\/fphar.2019.00740 (2019).","journal-title":"Front. Pharmacol."},{"key":"9220_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan0630","author":"SM Shim","year":"2018","unstructured":"Shim, S. M. et al. The endoplasmic reticulum-residing chaperone BiP is short-lived and metabolized through N-terminal arginylation. Sci. Signal https:\/\/doi.org\/10.1126\/scisignal.aan0630 (2018).","journal-title":"Sci. Signal"},{"key":"9220_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03496","volume":"3","author":"J Wang","year":"2014","unstructured":"Wang, J., Pareja, K. A., Kaiser, C. A. & Sevier, C. S. Redox signaling via the molecular chaperone BiP protects cells against endoplasmic reticulum-derived oxidative stress. Elife 3, e03496. https:\/\/doi.org\/10.7554\/eLife.03496 (2014).","journal-title":"Elife"},{"key":"9220_CR36","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3389\/fphys.2018.01595","volume":"9","author":"T G\u00e1ll","year":"2018","unstructured":"G\u00e1ll, T. et al. Heme induces endoplasmic reticulum stress (HIER Stress) in human aortic smooth muscle cells. Front. Physiol. 9, 1595. https:\/\/doi.org\/10.3389\/fphys.2018.01595 (2018).","journal-title":"Front. Physiol."},{"key":"9220_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato, G. J., Steinberg, M. H. & Gladwin, M. T. Intravascular hemolysis and the pathophysiology of sickle cell disease. J. Clin. Invest. 127, 750\u2013760. https:\/\/doi.org\/10.1172\/JCI89741 (2017).","journal-title":"J. Clin. Invest."},{"key":"9220_CR38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/ajh.24544","volume":"91","author":"T Stehl\u00e9","year":"2016","unstructured":"Stehl\u00e9, T. et al. Reversible kidney iron accumulation in a patient with sickle cell disease treated with hydroxyurea. Am. J. Hematol. 91, 1283\u20131284. https:\/\/doi.org\/10.1002\/ajh.24544 (2016).","journal-title":"Am. J. Hematol."},{"key":"9220_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ki.2015.140","volume":"88","author":"J Lefebvre","year":"2015","unstructured":"Lefebvre, J. et al. Alternatively spliced isoforms of WT1 control podocyte-specific gene expression. Kidney Int. 88, 321\u2013331. https:\/\/doi.org\/10.1038\/ki.2015.140 (2015).","journal-title":"Kidney Int."},{"key":"9220_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm.3142","volume":"19","author":"CA Gebeshuber","year":"2013","unstructured":"Gebeshuber, C. A. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat. Med. 19, 481\u2013487. https:\/\/doi.org\/10.1038\/nm.3142 (2013).","journal-title":"Nat. Med."},{"key":"9220_CR41","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1681\/ASN.2016070711","volume":"28","author":"M Kasztan","year":"2017","unstructured":"Kasztan, M. et al. Long-term endothelin-a receptor antagonism provides robust renal protection in humanized sickle cell disease mice. J. Am. Soc. Nephrol. 28, 2443\u20132458. https:\/\/doi.org\/10.1681\/ASN.2016070711 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9220_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q. et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Sig. Transduct. Target. Ther. 9, 1\u201337. https:\/\/doi.org\/10.1038\/s41392-024-01757-9 (2024).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"9220_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan, M. J. & Liu, Z. Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell Res. 21, 103\u2013115. https:\/\/doi.org\/10.1038\/cr.2010.178 (2011).","journal-title":"Cell Res."},{"key":"9220_CR44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ki.2009.286","volume":"76","author":"SC Lee","year":"2009","unstructured":"Lee, S. C. et al. Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int. 76, 838\u2013848. https:\/\/doi.org\/10.1038\/ki.2009.286 (2009).","journal-title":"Kidney Int."},{"key":"9220_CR45","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1172\/JCI26857","volume":"116","author":"JD Belcher","year":"2006","unstructured":"Belcher, J. D. et al. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J. Clin. Invest. 116, 808\u2013816. https:\/\/doi.org\/10.1172\/JCI26857 (2006).","journal-title":"J. Clin. Invest."},{"key":"9220_CR46","doi-asserted-by":"publisher","first-page":"F255","DOI":"10.1152\/ajprenal.00160.2013","volume":"305","author":"S Bolisetty","year":"2013","unstructured":"Bolisetty, S. et al. Mitochondria-targeted heme oxygenase-1 decreases oxidative stress in renal epithelial cells. Am. J. Physiol. Renal Physiol. 305, F255\u2013F264. https:\/\/doi.org\/10.1152\/ajprenal.00160.2013 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"9220_CR47","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/sj.ki.5001565","volume":"70","author":"KA Nath","year":"2006","unstructured":"Nath, K. A. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 70, 432\u2013443. https:\/\/doi.org\/10.1038\/sj.ki.5001565 (2006).","journal-title":"Kidney Int."},{"key":"9220_CR48","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/toxins11110660","volume":"11","author":"M Frimat","year":"2019","unstructured":"Frimat, M., Boudhabhay, I. & Roumenina, L. T. Hemolysis derived products toxicity and endothelium: model of the second hit. Toxins (Basel) 11, 660. https:\/\/doi.org\/10.3390\/toxins11110660 (2019).","journal-title":"Toxins (Basel)"},{"key":"9220_CR49","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3390\/ijms22042009","volume":"22","author":"A Grunenwald","year":"2021","unstructured":"Grunenwald, A., Roumenina, L. T. & Frimat, M. Heme oxygenase 1: a defensive mediator in kidney diseases. Int. J. Mol. Sci. 22, 2009. https:\/\/doi.org\/10.3390\/ijms22042009 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"9220_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/01.mnh.0000437613.88158.d3","volume":"23","author":"KA Nath","year":"2014","unstructured":"Nath, K. A. Heme oxygenase-1 and acute kidney injury. Curr. Opin. Nephrol. Hypertens 23, 17\u201324. https:\/\/doi.org\/10.1097\/01.mnh.0000437613.88158.d3 (2014).","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"9220_CR51","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1038\/s41598-020-62016-9","volume":"10","author":"E Poulaki","year":"2020","unstructured":"Poulaki, E. et al. Podocyte-targeted Heme Oxygenase (HO)-1 overexpression exacerbates age-related pathology in the rat kidney. Sci. Rep. 10, 5719. https:\/\/doi.org\/10.1038\/s41598-020-62016-9 (2020).","journal-title":"Sci. Rep."},{"key":"9220_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00427-1","author":"AS De Vriese","year":"2021","unstructured":"De Vriese, A. S. et al. Therapeutic trials in adult FSGS: lessons learned and the road forward. Nat. Rev. Nephrol. https:\/\/doi.org\/10.1038\/s41581-021-00427-1 (2021).","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09220-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T15:21:38Z","timestamp":1753456898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09220-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9220"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09220-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27136"}}